An EGFR‐MAB therapy may be associated with strong dermatological toxicities, inflammations, Staphylococcus aureus superinfection, and hematopoietic side effects such as papulopustular rush, nail inflammation, dry skin, alopecia, increased growth of eyelashes and facial hair, and strong pruritus [9]. Here, EGFR is linked to neoplasm.